Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Rt Hon Greg Clark MP, Business, Energy and Industrial Strategy Secretary, has attended the inauguration of the Novo Nordisk Research Centre Oxford (NNRCO).

The day of events, including laboratory tours and a round table discussion on government policy on diabetes care and prevention, was also attended by Sir John Bell, Regius Chair of Medicine at the University of Oxford and Mads Krogsgaard Thomsen, Chief Science Officer of Novo Nordisk. The programme included speeches by Tommy Ahlers, the Danish Education and Research Minister and Lord O’Shaughnessy, Parliamentary Under Secretary of State for Health.

The new research centre is located on the Old Road Campus in Oxford amongst several University-led research institutes, including the Target Discovery Institute, Big Data Institute and OCDEM (Oxford Centre for Diabetes, Endocrinology and Metabolism). The new Innovation Building will house both Novo Nordisk and the BioEscalator that will rent out space for small start-up companies.

Read more

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.